AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 14, 2024
A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills.
pharmaphorum
JULY 14, 2024
Shares in Immutep shoot up after its LAG-3 inhibitor eftilagimod alfa revs up MSD's Keytruda in PD-L1-negative head and neck cancer
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 14, 2024
As the Union Budget approaches, the life sciences sector anticipates substantial support to enhance innovation and investment in the development of new chemical entities (NCEs) and new biological entities (NBEs). These initiatives are crucial for sustaining the sector’s growth trajectory and enhancing its global competitiveness.
pharmaphorum
JULY 14, 2024
Observational study finds lower risk of cognitive problems and nicotine dependence in diabetics using Novo Nordisk's Ozempic
Drug Patent Watch
JULY 14, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
BioSpace
JULY 14, 2024
After a busy first half of 2024, several companies are expecting key data readouts in the neuropsychiatric and neurodegenerative disease spaces during the next six months.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
JULY 14, 2024
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological - read this article along with other careers information, tips and advice on BioSpace
BioSpace
JULY 14, 2024
Cell therapy biotech Artiva Biotherapeutics plans to use the funds raised to support the development of its AlloNK therapy for systemic lupus erythematosus.
BioSpace
JULY 14, 2024
Halia Therapeutics, NodThera and Gain Therapeutics target neuroinflammatory processes in hopes of modifying the course of Parkinson’s progression.
BioSpace
JULY 14, 2024
Why I advocated on Capitol Hill this month for the renewal of the FDA’s Priority Review Voucher program
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Expert insights. Personalized for you.
222 
Let's personalize your content